Kleiman | Evangelista Eye Center is pleased to offer its patients the newest in lens implant technology, the Crystalens HD.
The first and only FDA-approved "accommodating" intraocular lens, the Crystalens HD automatically moves forward and backward with the eye's internal ciliary muscle to help patients with lens implants focus naturally at all distances.
In conventional lens implant surgery, which has been the standard treatment for cataracts for many years, the surgeon implants a fixed focus plastic or silicone artificial lens. This lens allows patients to see well at a distance but still requires glasses for reading.
In FDA clinical trials*, Crystalens HD patients enjoyed life-changing benefits. More than 98% of patients who received Crystalens HD implants in both eyes had uncorrected visual acuity of 20/30 or better at distance without glasses, and could read 6-point type on a medicine bottle. In addition, 92% had distance visual acuity of 20/25 or better. In Europe and Mexico, where the lens has been in use for more than five years, nearly all patients continued to enjoy this range of vision year after year. In these studies, 93.8% of patients surveyed said they could perform most daily activities without glasses.
Thanks to Crystalens HD, many people no longer have to suffer impaired or diminishing vision. Crystalens HD gives cataract and refractive surgeons a new way to provide the growing population of aging, yet youthful, people with the rejuvenating effects of high-performance vision without glasses or contacts.
At this time, most insurance plans do not cover the cost of the Crystalens HD implant. Your insurance may, however, cover the cost of surgery, anesthesia and surgery center fees. Contact Kleiman | Evangelista today to learn more about your own insurance coverage.
*Results are based on FDA trials. Individual results will vary. An evaluation with the doctors and surgeons at Kleiman Evangelista Eye Center will determine a treatment option based on your individual needs.